Collectively, several studies have demonstrated that the induction of AhR signaling has the capacity to attenuate autoimmune CNS inflammation, suggesting that AhR is an important therapeutic target that exemplifies the complexity of gut–brain interactions [139,140]. The gene discussed is AHR; the disease is inflammatory response.